SLNB remains a key staging procedure in clinically node-negative melanoma and provides prognostic information that can guide adjuvant therapy discussions. Current NCCN guidelines recommend discussing ...
By Karen Roman SkylineDx said its Merlin CP-GEP molecular test is uniquely recognized by the National Comprehensive Cancer Network (NCCN) for predictive use in select T1 and T2 melanoma patients. The ...
SkylineDx today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its Clinical Practice Guidelines in Oncology for Cutaneous Melanoma (Version 1.2026), recognizing Merlin ...
Please provide your email address to receive an email when new articles are posted on . The Merlin test, a clinical-pathologic and gene expression profile, was able to successfully classify 37% of ...
The study assessed the overall diagnostic accuracy of the Merlin CP-GEP Test for predicting sentinel node metastases and recurrence risk The Merlin CP-GEP Test demonstrated strong predictive and ...
BOSTON & MOJAVE, Calif.--(BUSINESS WIRE)--Merlin, the leading developer of safe, autonomous flight technology for fixed-wing aircraft, today announced it successfully began the flight test campaign of ...
BOSTON--(BUSINESS WIRE)--Merlin, the leading developer of assured autonomous flight technology for fixed-wing aircraft, today announced it’s rapidly progressing the flight test campaign of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results